Trengestone (INN) (brand names Reteroid, Retroid, Retrone; former developmental code name Ro 4-8347), also known as 6-chloro-6,7-didehydroretroprogesterone or 6-chloro-9β-10α-pregna-1,4,6-triene-3,20-dione, is a progestin of the retroprogesterone group related to dydrogesterone that was formerly used to treat menstrual disorders. It was synthesized in 1964 and was introduced for medical use by Roche in 1974.
